ImageneBio, Inc. (IMA)
NASDAQ · Healthcare
ImageneBio, Inc. Income Statement 2020–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|---|
| Revenues | ||||||
| Revenue | 800,000 | 3.5M | 9.2M | 15.6M | 31.0M | 9.2M |
| Gross Profit | — | — | — | — | — | — |
| Profitability | ||||||
| Operating Income | -48.5M | -37.0M | -75.4M | -70.9M | -34.1M | -44.5M |
| EBITDA | -48.1M | -35.9M | — | — | — | — |
| Net Income | -45.3M | -36.6M | -68.2M | -68.8M | -34.1M | -44.3M |
| Per Share Data | ||||||
| EPS (diluted) | $-9.64 | $-22.10 | $-1.63 | $-1.90 | $-1.22 | — |
| Shares Outstanding (dil.) | — | 48M | 42M | 36M | 28M | 3M |
ImageneBio, Inc. Income Statement — FAQ
ImageneBio, Inc. (IMA) income statement over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see IMA's income statement history?
The chart and table above show ImageneBio, Inc.'s income statement by year and by quarter, including the growth rate.